Dancann Pharma Management
Management criteria checks 1/4
Dancann Pharma's CEO is Jeppe Rasmussen, appointed in Jan 2018, has a tenure of 6.25 years. directly owns 3.55% of the company’s shares, worth $64.90K. The average tenure of the management team and the board of directors is 3.1 years and 2.3 years respectively.
Key information
Jeppe Rasmussen
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.3yrs |
| CEO ownership | 3.5% |
| Management average tenure | 3.1yrs |
| Board average tenure | 2.3yrs |
Recent management updates
Recent updates
CEO
Jeppe Rasmussen (28 yo)
6.3yrs
Tenure
Mr. Jeppe Krog Rasmussen has been Director of Dancann Pharma A/S since September 20, 2022. He Founded and serves as Chief Executive Officer of Dancann Pharma A/S since 2018 and serves as its Member of Exec...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 6.3yrs | no data | 3.55% $ 64.9k | |
| Chief Financial Officer | 1.3yrs | no data | no data | |
| Head of Production | 3.1yrs | no data | no data | |
| Chief Commercial Officer | 4.3yrs | no data | no data | |
| Head of Quality Assurance | 1.7yrs | no data | no data |
3.1yrs
Average Tenure
Experienced Management: DCPX.F's management team is considered experienced (3.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 1.6yrs | no data | 3.55% $ 64.9k | |
| Chairman of the Board | 4.3yrs | no data | 0.25% $ 4.5k | |
| Vice-Chairman | 3yrs | no data | 0.15% $ 2.7k | |
| Additional Director | less than a year | no data | no data |
2.3yrs
Average Tenure
39yo
Average Age
Experienced Board: DCPX.F's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.